BEYOND AIR INC (XAIR)
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
$3.53-1.67%
Close 2026-09-04 · 1-day change
NASDAQHealth CareMedical - DevicesSnapshot 2026-09-04
QuarterlyIQ Insights · XAIR
Income statement, balance sheet, and cash flow — annual and quarterly history, as reported.
Figures in millions of None, except per-share and ratios.
| TTM | Mar 2026 | Mar 2025 | Mar 2024 | Mar 2023 | Mar 2022 | Mar 2021 | Mar 2020 | Mar 2019 | Mar 2018 | Mar 2017 | Mar 2016 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenues | ||||||||||||
| Revenues | 7.7 | 7.7 | 3.7 | 1.2 | — | — | 0.9 | 1.4 | 7.7 | — | — | — |
| Total Revenues | 0.4 | 0.3 | — | — | — | — | — | — | — | — | — | — |
| Cost of Revenues | 7.4 | 7.4 | 5.4 | 2.5 | 0.6 | — | — | — | — | — | — | — |
| Gross Profit | — | 0.3 | (1.7) | (1.3) | (0.6) | — | — | — | — | — | — | — |
| Operating Expenses & Income | ||||||||||||
| Selling, General & Admin | 19.2 | 19.1 | 26.0 | — | — | — | — | — | — | — | — | — |
| R&D Expenses | 9.1 | 10.2 | 16.9 | 24.4 | 16.8 | 11.8 | 12.6 | 10.6 | 3.9 | 4.4 | 4.4 | — |
| Operating Income | (28.0) | (29.0) | (44.5) | (63.0) | (52.1) | (40.7) | (22.2) | (18.1) | (3.1) | (11.1) | (11.1) | 2.3 |
| Earnings from Continuing Operations | ||||||||||||
| Interest Expense | — | 3.5 | 3.0 | 2.9 | 0.0 | 0.8 | 0.6 | 0.0 | — | — | — | 0.0 |
| Other Non-Operating Income / Expenses | (6.4) | (5.3) | (3.9) | (1.3) | (7.3) | (3.4) | (0.7) | (2.0) | (3.5) | (7.0) | (7.0) | — |
| Asset Writedown | — | — | — | 0.0 | 0.2 | — | — | — | — | — | — | — |
| EBT, Incl. Unusual Items | (34.4) | (34.3) | (48.5) | (64.3) | (59.4) | (44.1) | (22.9) | (20.1) | — | 18.0 | 18.0 | — |
| Income Tax Expense | — | — | — | — | — | — | — | (0.2) | — | 0.0 | 0.0 | — |
| Net Income | ||||||||||||
| Minority Interest | (0.9) | (1.1) | (1.9) | (4.1) | (3.6) | (0.9) | — | — | — | — | — | — |
| Net Income | (33.5) | (33.2) | (46.6) | (60.2) | (55.8) | (43.2) | (22.9) | (19.9) | (6.6) | (18.0) | (18.0) | (3.7) |
| Per Share | ||||||||||||
| Basic EPS | (46.43) | (4.01) | (0.69) | (1.82) | (1.86) | (1.68) | (1.27) | — | (0.77) | (3.01) | — | — |
| Diluted EPS | (46.43) | (4.01) | (0.69) | (1.82) | (1.86) | — | — | — | (0.77) | (3.01) | — | — |
| Revenue per Share | 0.52 | — | — | — | — | — | — | — | — | — | — | — |
| Basic Weighted Avg Shares | 0.7 | 8.3 | 67.7 | 33.2 | 30.0 | 25.7 | 18,005.2 | — | 8.5 | 6.0 | — | — |
| Diluted Weighted Avg Shares | 0.7 | 8.3 | 67.7 | 33.2 | 30.0 | — | — | — | 8.5 | 6.0 | — | — |
| Supplemental | ||||||||||||
| EBITDA | — | (25.9) | (41.5) | (61.2) | (51.5) | (40.4) | (22.0) | (18.0) | (3.0) | — | — | — |
| EBIT | (28.0) | (29.0) | (44.5) | (63.0) | (52.1) | (40.7) | (22.2) | (18.1) | (3.1) | (11.1) | (11.1) | 2.3 |
| Effective Tax Rate | — | — | — | — | — | — | — | 0.8% | — | 0.1% | 0.1% | — |
Not investment advice. Scores describe historical and current data; they are not forecasts of future returns. Consult a licensed advisor before making investment decisions.